News
- First-in-class approved for COPD
- Published on Jul 30, 2010
Nycomed’s novel anti-inflammatory roflumilast will soon be available in the EU following a positive opinion from the European Medicine Agency’s Committee for Medicinal Products for Human Use.
- New cancer drug targets microtubules
- Published on Jul 30, 2010
Data presented at the American Association of Cancer Research Annual Meeting in Washington DC show that Basilea’s novel small molecule anticancer drug BAL 101553 is potentially effective against a wide range of tumour types, including some resistant to chemotherapy.
- More on cladribine in multiple sclerosis
- Published on Jul 30, 2010
Further analysis of the CLARITY trial has provided more information about the effectiveness of the lymphocyte-depleting agent cladribine in the treatment of multiple sclerosis.
- New treatment target for autoimmune disease?
- Published on Jul 30, 2010
Researchers at Leicester University have discovered a new mechanism regulating B-cell activation that could open the way for new treatments for autoimmune diseases (Nature 2010;11:265–72).
- Pitavastatin efficacy
- Published on Jul 30, 2010
Kowa’s new statin maintains reductions in LDL-cholesterol (LDL-C) during a year’s treatment with no evidence of new adverse events.